Financials data is unavailable for this security.
View more
Year on year Nanjing Medlander Medical Technology Co Ltd 's revenues fell -9.57% from 376.89m to 340.82m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 121.68m to 89.82m, a -26.19% decrease.
| Gross margin | 71.46% |
|---|---|
| Net profit margin | 27.94% |
| Operating margin | 31.03% |
| Return on assets | 7.06% |
|---|---|
| Return on equity | 7.56% |
| Return on investment | 7.76% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Nanjing Medlander Medical Technology Co Ltd fell by 184.21m. However, the company earned 136.91m from its operations for a Cash Flow Margin of 40.17%. In addition the company used 237.43m on investing activities and also paid 83.69m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 13.10 |
|---|---|
| Tangible book value per share | 11.99 |
More ▼
Balance sheet in CNYView more
| Current ratio | 8.04 |
|---|---|
| Quick ratio | 7.57 |
| Total debt/total equity | 0.012 |
|---|---|
| Total debt/total capital | 0.0115 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -53.85% and -38.49%, respectively.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 97.73% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -33.95 |
More ▼
